Parkinson’s Disease Latest Research

84 new pubmed citations were retrieved for your search. Click on the search hyperlink below to display the complete search results: parkinson's disease These pubmed results were generated on 2018/12/12PubMed comprises more than millions of citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may ... read more

84 new pubmed citations were retrieved for your search. Click on the search hyperlink below to display the complete search results: parkinson's disease These pubmed results were generated on 2018/12/12PubMed comprises more than millions of citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may ... read more

61 new pubmed citations were retrieved for your search. Click on the search hyperlink below to display the complete search results: parkinson's disease These pubmed results were generated on 2018/12/07PubMed comprises more than millions of citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may ... read more

The Role of NADPH Oxidases and Oxidative Stress in Neurodegenerative Disorders. Int J Mol Sci. 2018 Nov 30;19(12): Authors: Tarafdar A, Pula G Abstract For a number of years, nicotinamide adenine dinucleotide phosphate (NADPH) oxidases (NOX) was synonymous with NOX2/gp91phox and was considered to be a peculiarity of professional phagocytic ... read more

Nurr1 (NR4A2) regulates Alzheimer's disease-related pathogenesis and cognitive function in the 5XFAD mouse model. Aging Cell. 2018 Dec 04;:e12866 Authors: Moon M, Jung ES, Jeon SG, Cha MY, Jang Y, Kim W, Lopes C, Mook-Jung I, Kim KS Abstract The orphan nuclear receptor Nurr1 (also known as NR4A2) is critical ... read more

Dynamin-related protein 1: A critical protein in the pathogenesis of neural system dysfunctions and neurodegenerative diseases. J Cell Physiol. 2018 Dec 04;: Authors: Qi Z, Huang Z, Xie F, Chen L Abstract Mitochondria play a key role in the maintenance of neuronal function by continuously providing energy. Here, we will ... read more

Comment on "Is it Useful to Classify PSP and CBD as Different Disorders?" Mov Disord Clin Pract. 2018 Sep-Oct;5(5):564-565 Authors: Lang AE PMID: 30515448 [PubMed] ... read more

Neurostimulation for Functional Neurological Disorder: Evaluating Longitudinal Neurophysiology. Mov Disord Clin Pract. 2018 Sep-Oct;5(5):561-563 Authors: Burke MJ, Isayama R, Jegatheeswaran G, Gunraj C, Feinstein A, Lang AE, Chen R PMID: 30515447 [PubMed] ... read more

Levodopa/Carbidopa Intestinal Gel Infusion Therapy: Focus on Gait and Balance. Mov Disord Clin Pract. 2018 Sep-Oct;5(5):542-545 Authors: Rispoli V, Golfrè Andreasi N, Penna G, Preda F, Contini E, Sensi M Abstract Background: Gait and balance disorders in advanced Parkinson's disease (aPD) heavily impact the disease burden. In this prospective observational ... read more

Dyskinesia-Hyperpyrexia Syndrome in Parkinson's Disease: A Heat Shock-Related Emergency? Mov Disord Clin Pract. 2018 Sep-Oct;5(5):534-537 Authors: Sarchioto M, Ricchi V, Melis M, Deriu M, Arca R, Melis M, Morgante F, Cossu G PMID: 30515444 [PubMed] ... read more

Missing Data in the Unified Dysksinesia Rating Scale (UDysRS). Mov Disord Clin Pract. 2018 Sep-Oct;5(5):523-526 Authors: Luo S, Ren X, Han W, Goetz CG, Stebbins GT Abstract Objective: Identify the number of allowable missing values still permitting valid surrogate score calculation for the Unified Dyskinesia Rating Scale (UDysRS). Background: Missing ... read more

The Outcome of Dopamine Dysregulation Syndrome in Parkinson's Disease: A Retrospective Postmortem Study. Mov Disord Clin Pract. 2018 Sep-Oct;5(5):519-522 Authors: Barbosa P, Djamshidian A, Lees AJ, Warner TT Abstract Introduction: We have performed a retrospective analysis of the frequency and relation to treatment of dopamine dysregulation syndrome (DDS) using the ... read more

The 10-year Landscape of United States-Registered Parkinson Disease Clinical Trials: 2007-2016. Mov Disord Clin Pract. 2018 Sep-Oct;5(5):512-518 Authors: Wyant KJ, Yasuda E, Kotagal V Abstract Background: We know little about how well the goals and results of clinical trials in Parkinson disease (PD) reflect the priorities of patients and the ... read more

Phenoconversion from Idiopathic Rapid Eye Movement Sleep Behavior Disorder to Lewy Body Disease. Mov Disord Clin Pract. 2018 Sep-Oct;5(5):506-511 Authors: Miyamoto T, Miyamoto M Abstract Background: The conversion rate and estimated risk of neurodegenerative diseases vary with idiopathic rapid eye movement sleep behavior disorder (IRBD). Methods: This retrospective cohort study ... read more

Clinical Rating Scales for Urinary Symptoms in Parkinson Disease: Critique and Recommendations. Mov Disord Clin Pract. 2018 Sep-Oct;5(5):479-491 Authors: Pavy-Le Traon A, Cotterill N, Amarenco G, Duerr S, Kaufmann H, Lahrmann H, Tison F, Wenning GK, Goetz CG, Poewe W, Sampaio C, Schrag A, Rascol O, Martinez-Martin P, Stebbins GT, ... read more

Diagnostic validity of biomarkers in Parkinson's Disease: systematic review and meta-analysis. Rev Bras Enferm. 2018 Nov-Dec;71(6):3074-3083 Authors: Costa MFBNAD, Reisdorfer E, Kempfer SS, Fernandes GCM, Porporatti AL, Canto GL Abstract OBJECTIVE: To identify biomarkers for Parkinson's disease, cerebrospinal fluid, blood, saliva, and urine. METHOD: The studies were collected from the ... read more

Understanding, Impact, and Communication of "Off" Periods in Parkinson's Disease: A Scoping Review. Mov Disord Clin Pract. 2018 Sep-Oct;5(5):461-470 Authors: Rastgardani T, Armstrong MJ, Gagliardi AR, Marras C Abstract Background: Off periods are a common and disabling symptom of Parkinson's disease. We reviewed published research on understanding, impact, and communication ... read more

Diagnostic Validation for Participants in the Washington State Parkinson Disease Registry. Parkinsons Dis. 2018;2018:3719578 Authors: Kim HM, Leverenz JB, Burdick DJ, Srivatsal S, Pate J, Hu SC, Millard SP, Davis MY, Samii A, Zabetian CP Abstract Background: The Washington State Parkinson Disease Registry (WPDR) was created to facilitate recruitment for ... read more

A Critical Role of Autophagy in Regulating Microglia Polarization in Neurodegeneration. Front Aging Neurosci. 2018;10:378 Authors: Jin MM, Wang F, Qi D, Liu WW, Gu C, Mao CJ, Yang YP, Zhao Z, Hu LF, Liu CF Abstract Neuroinflammation and autophagy dysfunction are closely related to the development of neurodegeneration such ... read more

Computational affinity maturation of camelid single-domain intrabodies against the nonamyloid component of alpha-synuclein. Sci Rep. 2018 Dec 04;8(1):17611 Authors: Mahajan SP, Meksiriporn B, Waraho-Zhmayev D, Weyant KB, Kocer I, Butler DC, Messer A, Escobedo FA, DeLisa MP Abstract Improving the affinity of protein-protein interactions is a challenging problem that is ... read more

Functional and behavioral consequences of Parkinson's disease-associated LRRK2-G2019S mutation. Biochem Soc Trans. 2018 Dec 04;: Authors: Benson DL, Matikainen-Ankney BA, Hussein A, Huntley GW Abstract LRRK2 mutation is the most common inherited, autosomal dominant cause of Parkinson's disease (PD) and has also been observed in sporadic cases. Most mutations result ... read more

FDG-PET hypometabolism is more sensitive than MRI atrophy in Parkinson's disease: A whole-brain multimodal imaging meta-analysis. Neuroimage Clin. 2018 Nov 15;: Authors: Albrecht F, Ballarini T, Neumann J, Schroeter ML Abstract Recently, revised diagnostic criteria for Parkinson's disease (PD) were introduced (Postuma et al., 2015). Yet, except for well-established dopaminergic ... read more

Successful pallidotomy for post-hyperglycemic hemichorea-ballism. Parkinsonism Relat Disord. 2018 Nov 28;: Authors: De Vloo P, Breen DP, Milosevic L, Lee DJ, Dallapiazza RF, Hutchison WD, Lang AE, Lozano AM PMID: 30514649 [PubMed - as supplied by publisher] ... read more

Molecular Docking Studies of Methamphetamine and Amphetamine-Related Derivatives as an Inhibitor against dopamine Receptor. Curr Comput Aided Drug Des. 2018 Dec 04;: Authors: Foroughi K, Khaksari M, Shayannia A Abstract BACKGROUND: The catecholamines such as dopamine, norepinephrine, and epinephrine are neurotransmitters that regulate different physiological functions of the central nervous ... read more

High-intensity interval training in people with Parkinson's disease: a randomized, controlled feasibility trial. Clin Rehabil. 2018 Dec 04;:269215518815221 Authors: Harvey M, Weston KL, Gray WK, O'Callaghan A, Oates LL, Davidson R, Walker RW Abstract OBJECTIVES:: To investigate whether people with Parkinson's disease can exercise at a high-intensity across a 12-week ... read more